Vol 9, No 2 (2017)
Mol Cell Pharmacol
Table of Contents
Spotlight
| Spotlight on Dr. Jie An: a Pharmacogenomics and Personalized Medicine Expert | Abstract PDF |
| Jie An | 9-10 |
FDA Corner
| FDA Expands Approved Use of Kalydeco to Treat Additional Mutations of Cystic Fibrosis | Abstract PDF |
| 11 |
| FDA Approves First Cancer Treatment for Any Solid Tumor With a Specific Genetic Feature | Abstract PDF |
| 11-12 |
| FDA Approves New Treatment to Reduce the Risk of Breast Cancer Returning | Abstract PDF |
| 13 |
| FDA Approves Treatment for Chronic Graft Versus Host Disease | Abstract PDF |
| 13-14 |
Our partner: Crossroads Pharmacy 2800 Hwy 101, Rogersville, AL 35652 LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 Copyright © 2008 LumiText Publishing. All rights reserved.